Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03806192 · ClinicalTrials.gov registry record · NA
Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia
A NA study, sponsored by University of Washington.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03806192: Clinical Trial NA study, sponsored by University of Washington.
NCT03806192 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03806192, a NA study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This trial studies the feasibility of delivering the Partners in Care Program to caregivers of patients with acute myeloid leukemia. Psychological counseling interventions, such as the Partners in Care Program, may help to improve caregivers' psychosocial functioning, marital adjustment in the context of the cancer, communication, and support skills to the patient.
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Telephone-Based Intervention
- OTHER Behavioral, Psychological or Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-03-16 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
Why NCT03806192 stopped before completion
NCT03806192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03806192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03806192 about?
NCT03806192 is a clinical study titled "Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia". This trial studies the feasibility of delivering the Partners in Care Program to caregivers of patients with acute myeloid leukemia. Psychological counseling interventions, such as the Partners in Care Program, may help to improve caregivers' psychosocial functioning, marital adjustment in the conte...
What is the current status of trial NCT03806192?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2019-03-16. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT03806192?
The interventions under investigation include: Questionnaire Administration (OTHER), Telephone-Based Intervention (BEHAVIORAL), Behavioral, Psychological or Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT03806192?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03806192's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI